Titan Pharmaceuticals Inc (TTNP)

[Doctor Detroit]

I don't see any conflict. Business is business. Braeburn licensed injectables from Camrus after all, which could be seen to compete with probuphine.

For indivior, there isn't a conflict either. They have no six month implant in the US, and there isn't any planned. So why not try to make some money on one in the EU?

It's interesting that Indivior characterizes its injectables as an "implant" because while liquid when injected, it quickly forms into a solid. I can see a marketing strategy where they promote the benefits of their one month and six month implants, verses Braeburn's implant which remains liquid but forms a shell around the surface, e.g., both implants can be removed in case of an emergency, and also there is no risk of dose dumping.